Rallybio Corp — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Stephen Uden (CEO) and Jonathan I. Lieber (CFO) signed standard Sarbanes-Oxley 302 and 906 certifications for the Q2 2026 10-Q ending June 30, 2026, filed August 6, 2026. Both officers certify the report contains no untrue material statements, financial statements fairly present the company's condition, and disclosure controls and internal controls are effective. No specific financial results, transactions, or operational changes are disclosed in these certification exhibits alone.
Why this rating
These are boilerplate SOX certifications—routine regulatory filings required for all public companies. No substantive business, financial, or operational disclosure present.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.